Ebola vaccine halves the chance of dying from the disease, new study says. The injection not only interrupts the transmission of the virus, but also increases the survival rate among those who had already been infected.
Researchers analyzed the cases of 2,279 confirmed Ebola patients between July 2018 and April 2020 in the Democratic Republic of the Congo (DRC) According to their findings, 56% of the unvaccinated died, compared to 25% of those who received the Ervebo injection.